Liam Bosch, MD
Adult Reconstructive Orthopaedic Surgery · Redwood City, CANPI 1750814554
Payments from drug & device makers
What this record shows
This record is dominated by education: $11,612 of the $15,915 with a category attached, or 73.0%. 13 manufacturers reported payments, led by Smith+Nephew at 40.9% of the total. Reporting peaked in 2023 at $6,112 and has fallen 97.6% since, to $146 in 2025.
Across 40 payments — averaging $397.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$7K
- Evolution Surgical, Inc$5K
- Encore Medical, LP$2K
- Stryker$1K
- Johnson & Johnson$291
- Corentec America Inc$235
- plus $832 from 7 others
What the payments were for
- Speaking & faculty fees$1,5009%
- Travel & lodging$5413%
- Food & beverage$2,26214%
- Education$11,61273%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 5 | $6,504 |
| Evolution Surgical, Inc | 5 | $5,280 |
| Encore Medical, LP | 1 | $1,500 |
| Stryker | 10 | $1,272 |
| Johnson & Johnson | 7 | $291 |
| Corentec America Inc | 1 | $235 |
| Biotronik Inc. | 1 | $153 |
| Wishbone Medical Inc. | 1 | $150 |
| Davol Inc. | 1 | $149 |
| Medical Device Business Services, Inc. | 3 | $120 |
| Biosense Webster, Inc. | 1 | $114 |
| Exactech, Inc. | 1 | $89 |
| Boston Scientific | 3 | $57 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO SURGICAL$3,000
- MAKO$943
- Corentec$235
- TRIATHLON$168
- BioMonitor$153
- Solia$153
- QDOT MICRO Catheter$114
- Carto 3$114
How this compares
$15,915 in reported general payments places this provider in the 55th percentile of 136 adult reconstructive orthopaedic surgery providers in California.
See all adult reconstructive orthopaedic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $5,248 |
| Celecoxib | 62 | $1,869 |
| Oxycodone Hcl | 178 | $1,045 |
| Famotidine | 113 | $842 |
| Ondansetron OdtOndansetron | 115 | $780 |
| Meloxicam | 158 | $382 |
| Mupirocin | 37 | $248 |
| Amoxicillin | 75 | $194 |
| Tramadol Hcl | 50 | $184 |
| Clindamycin Hcl | 22 | $141 |
| Hydromorphone Hcl | 12 | $78 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Redwood City
- William MaloneyStanford$11.1M
- James CaillouetteNewport Beach$4.8M
- William LongLos Angeles$2.8M
- John DearbornMenlo Park$2.5M
- William Bugbeela Jolla$2.1M
- James HuddlestonStanford$1.5M
- Alexander SahFremont$1.2M
- John DianaNapa$981K
- Thomas DonaldsonColton$893K
- Derek AmanatullahStanford$828K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.